A Study to Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy

NCT04058704 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

296

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer
Brain Metastases

Interventions

DRUG: Icotinib
RADIATION: SRS/WBRT/HA-WBRT/SMART

Sponsor

Betta Pharmaceuticals Co., Ltd.